Clinical outcomes in cardiac patients with COVID-19 in an Intensive Care Unit: An integrative review
DOI:
https://doi.org/10.33448/rsd-v12i8.42801Keywords:
Intensive Care Units; Heart diseases; COVID-19.Abstract
Objective: to identify in the scientific literature the main changes that occur as clinical predictors of unfavorable evolution in patients with heart diseases infected by COVID-19 Methodology: This is an integrative review built based on six steps predefined in the literature. The search for articles took place in the databases: BVS, PUBMED and CINAHAL. Inclusion criteria were: articles published in English, Portuguese or Spanish, from 2020 to 2023, available in full. Exclusion criteria were: duplicate articles, gray literature. Results: Nine scientific articles were selected to compose this review. The present study analyzed a total sample of 24,878 individuals, compiled from nine different articles. Results revealed that patients with COVID-19 who required ICU admission faced an increased risk of cardiac events in the post-infection period. The presence of Troponin I and T was identified as a significant predictor of adverse outcomes in these patients. The presence of pre-existing cardiovascular diseases is a significant risk factor for mortality in patients hospitalized in the ICU due to COVID-19. Patients with diabetes, hypertension and dyslipidemia had a higher risk of death. The most relevant finding was that high levels of troponin increased the chances of complications during hospital stay, ICU admission and mortality. Final considerations: Diabetes, hypertension, dyslipidemia, if present, increase the risk of death from COVID-19. In addition, arrhythmias, bradycardia, myocarditis and ischemia were associated with unfavorable disease outcomes.
References
Almeida Junior, G. L. G. de, Braga, F., Jorge, J. K., Nobre, G. F., Kalichsztein, M., Faria, P. de M. P. de, Bussade, B., Penna, G. L., Alves, V. O., Pereira, M. A., Gorgulho, P. de C., Faria, M. R. dos S. E. de, Drumond, L. E., Carpinete, F. B. S., Neno, A. C. L. B., & Neno, A. C. de A. (2020). Valor Prognóstico da Troponina T e do Peptídeo Natriurético Tipo B em Pacientes Internados por COVID-19. Arquivos Brasileiros de Cardiologia, 115, 660–666. https://doi.org/10.36660/abc.20200385
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA, 323(16), 1612–1614. https://doi.org/10.1001/jama.2020.4326
Bandyopadhyay, D., Akhtar, T., Hajra, A., Gupta, M., Das, A., Chakraborty, S., Pal, I., Patel, N., Amgai, B., Ghosh, R. K., Fonarow, G. C., Lavie, C. J., & Naidu, S. S. (2020). COVID-19 Pandemic: Cardiovascular Complications and Future Implications. American Journal of Cardiovascular Drugs, 20(4), 311–324. https://doi.org/10.1007/s40256-020-00420-2
Bardají, A., Carrasquer, A., Sánchez-Giménez, R., Lal-Trehan, N., del-Moral-Ronda, V., Peiró, Ó. M., Bonet, G., Castilho, G., Fort-Gallifa, I., Benavent, C., Recio, G., Gutiérrez, C., Villavicencio, C., Auguet, T., & Boqué, C. (2021). Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Revista Española de Cardiología (English Edition), 74(1), 24–32. https://doi.org/10.1016/j.rec.2020.08.027
Chapman, A. R., Bularga, A., & Mills, N. L. (2020). High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation, 141(22), 1733–1735. https://doi.org/10.1161/CIRCULATIONAHA.120.047008
Collard, D., Nurmohamed, N. S., Kaiser, Y., Reeskamp, L. F., Dormans, T., Moeniralam, H., Simsek, S., Douma, R., Eerens, A., Reidinga, A. C., Elbers, P. W. G., Beudel, M., Vogt, L., Stroes, E. S. G., & Born, B.-J. H. van den. (2021). Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: A prospective cohort study. BMJ Open, 11(2), e045482. https://doi.org/10.1136/bmjopen-2020-045482
Corrales-Medina, V. F., Alvarez, K. N., Weissfeld, L. A., Angus, D. C., Chirinos, J. A., Chang, C.-C. H., Newman, A., Loehr, L., Folsom, A. R., Elkind, M. S., Lyles, M. F., Kronmal, R. A., & Yende, S. (2015). Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease. JAMA, 313(3), 264–274. https://doi.org/10.1001/jama.2014.18229
Deng, Y., Xie, W., Liu, T., Wang, S., Wang, M., Zan, Y., Meng, X., Deng, Y., Xiong, H., & Fu, X. (2021). Associação da Hipertensão com a Gravidade e a Mortalidade de Pacientes Hospitalizados com COVID-19 em Wuhan, China: Estudo Unicêntrico e Retrospectivo. Arquivos Brasileiros de Cardiologia, 117, 911–921. https://doi.org/10.36660/abc.20200733
Doyen, D., Dupland, P., Morand, L., Fourrier, E., Saccheri, C., Buscot, M., Hyvernat, H., Ferrari, E., Bernardin, G., Cariou, A., Mira, J.-P., Jamme, M., Dellamonica, J., & Jozwiak, M. (2021). Characteristics of Cardiac Injury in Critically Ill Patients with Coronavirus Disease 2019. Chest, 159(5), 1974–1985. https://doi.org/10.1016/j.chest.2020.10.056
Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine, 8(4), e21. https://doi.org/10.1016/S2213-2600(20)30116-8
Feitoza, T. M. O., Chaves, A. M., Muniz, G. T. S., Cruz, M. C. C. da, & Junior, I. de F. C. (2020). Comorbidades e COVID-19. Revista Interfaces: Saúde, Humanas e Tecnologia, 8(3), 711–723. https://doi.org/10.16891/800
Hessami, A., Shamshirian, A., Heydari, K., Pourali, F., Alizadeh-Navaei, R., Moosazadeh, M., Abrotan, S., Shojaie, L., Sedighi, S., Shamshirian, D., & Rezaei, N. (2021). Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. The American Journal of Emergency Medicine, 46, 382–391. https://doi.org/10.1016/j.ajem.2020.10.022
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Labbé, V., Ederhy, S., Lapidus, N., Salem, J.-E., Trinh-Duc, A., Cohen, A., Fartoukh, M., & Voiriot, G. (2021). Characterization and outcomes of acute myocardial injury in COVID-19 intensive care patients. Infection, 49(3), 563–566. https://doi.org/10.1007/s15010-020-01560-y
Lippi, G., Lavie, C. J., & Sanchis-Gomar, F. (2020). Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Progress in Cardiovascular Diseases, 63(3), 390–391. https://doi.org/10.1016/j.pcad.2020.03.001
López, A. G., Cardentey, M. C., Betancourt, A. M., Chirino, O. C., López, F. M., & Rodríguez, R. F. (2020). Arritmias cardíacas en pacientes con la COVID-19. Escenarios y tratamiento. Revista Cubana de Cardiología y Cirugía Cardiovascular, 26(3), 1–12.
Martins, J. D. N., Sardinha, D. M., Silva, R. R. da, Lima, K. V. B., & Lima, L. N. G. C. (2020). As implicações da COVID-19 no sistema cardiovascular: Prognóstico e intercorrências. Journal of Health & Biological Sciences, 8(1), Artigo 1. https://doi.org/10.12662/2317-3076jhbs.v8i1.3355.p1-9.2020
Nascimento, J. H. P., Gomes, B. F. de O., & Oliveira, G. M. M. de. (2020). Troponina Cardíaca como Preditor de Injúria Miocárdica e Mortalidade por COVID-19. Arquivos Brasileiros de Cardiologia, 115, 667–668. https://doi.org/10.36660/abc.20200862
Parwani, A. S., Haug, M., Keller, T., Guthof, T., Blaschke, F., Tscholl, V., Biewener, S., Kamieniarz, P., Zieckler, D., Kruse, J., Angermair, S., Treskatsch, S., Müller-Redetzky, H., Pieske, B., Stangl, K., Landmesser, U., Boldt, L.-H., Huemer, M., & Attanasio, P. (2021). Cardiac arrhythmias in patients with COVID-19: Lessons from 2300 telemetric monitoring days on the intensive care unit. Journal of Electrocardiology, 66, 102–107. https://doi.org/10.1016/j.jelectrocard.2021.04.001
Raad, M., Dabbagh, M., Gorgis, S., Yan, J., Chehab, O., Dagher, C., Jamoor, K., Hussein, I. H., Cook, B., Van Harn, M., Singh, G., McCord, J., & Parikh, S. (2020). Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19. The American Journal of Cardiology, 133, 154–161. https://doi.org/10.1016/j.amjcard.2020.07.040
Raman, B., Bluemke, D. A., Lüscher, T. F., & Neubauer, S. (2022). Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. European Heart Journal, 43(11), 1157–1172. https://doi.org/10.1093/eurheartj/ehac031
Ribeiro, A. C., & Uehara, S. C. da S. A. (2022). Hipertensão arterial sistêmica como fator de risco para a forma grave da covid-19: Revisão de escopo. Revista de Saúde Pública, 56, 20.
Sousa, L. M. M., Marques-Vieira, C. M. A., Severino, S. S. P., & Antunes, A. V. (2017). A metodologia de revisão integrativa da literatura em enfermagem. Revista Investigação em Enfermagem, 17(1), 17–26.
Tajarernmuang, P., Trongtrakul, K., Chaiwong, W., Nantsupawat, T., Deesomchok, A., Chanayat, P., Niyatiwatchanchai, N., Theerakittikul, T., Limsukon, A., Pothirat, C., Liwsrisakun, C., & Bumroongkit, C. (2022). Bradycardia and Heart Rate Fluctuation Are Associated with a Prolonged Intensive Care Unit Stay in Patients with Severe COVID-19. Medicina, 58(7), Artigo 7. https://doi.org/10.3390/medicina58070950
Thumiki, V. R. R., & Jurcic, A. (2021). Impact of COVID-19 Crisis on Knowledge Management Practices in Sultanate of Oman. Electronic Journal of Knowledge Management, 19(3), Artigo 3. https://doi.org/10.34190/ejkm.19.3.2102
Wiemken, T. L., McGrath, L. J., Andersen, K. M., Khan, F., Malhotra, D., Alfred, T., Nguyen, J. L., Puzniak, L., Thoburn, E., Jodar, L., & McLaughlin, J. M. (2023). Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events. Clinical Infectious Diseases, 76(3), e42–e50. https://doi.org/10.1093/cid/ciac661
Zeng, J.-H., Wu, W.-B., Qu, J.-X., Wang, Y., Dong, C.-F., Luo, Y.-F., Zhou, D., Feng, W.-X., & Feng, C. (2020). Cardiac manifestations of COVID-19 in Shenzhen, China. Infection, 48(6), 861–870. https://doi.org/10.1007/s15010-020-01473-w
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), Artigo 5. https://doi.org/10.1038/s41569-020-0360-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gabriela Nascimento Barreto; Mônica Gomes de Oliveira; Luana Ferreira Campos; Carina Santana Ferreira Marques; Rosane Milet Passos Teixeira; Carla Viviane Freitas de Jesus; Arthur Cesar de Melo Tavares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
